Fluorine in PDB 7rio: Human Pxr Lbd Bound to GSK003
Protein crystallography data
The structure of Human Pxr Lbd Bound to GSK003, PDB code: 7rio
was solved by
S.P.Williams,
G.B.Wisely,
P.Ward,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
31.16 /
2.48
|
Space group
|
P 43 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
91.392,
91.392,
85.211,
90,
90,
90
|
R / Rfree (%)
|
20.7 /
27.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Pxr Lbd Bound to GSK003
(pdb code 7rio). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
Human Pxr Lbd Bound to GSK003, PDB code: 7rio:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 7rio
Go back to
Fluorine Binding Sites List in 7rio
Fluorine binding site 1 out
of 3 in the Human Pxr Lbd Bound to GSK003
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Pxr Lbd Bound to GSK003 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:46.0
occ:1.00
|
F1
|
A:5YX501
|
0.0
|
46.0
|
1.0
|
C22
|
A:5YX501
|
1.3
|
62.5
|
1.0
|
C23
|
A:5YX501
|
2.3
|
58.0
|
1.0
|
C21
|
A:5YX501
|
2.4
|
58.4
|
1.0
|
O
|
A:HIS407
|
3.5
|
38.5
|
1.0
|
N
|
A:LEU411
|
3.5
|
33.4
|
1.0
|
C24
|
A:5YX501
|
3.6
|
50.3
|
1.0
|
C20
|
A:5YX501
|
3.6
|
53.8
|
1.0
|
CB
|
A:LEU411
|
3.7
|
36.2
|
1.0
|
CA
|
A:LEU411
|
3.8
|
39.9
|
1.0
|
C10
|
A:5YX501
|
3.8
|
61.2
|
1.0
|
CB
|
A:ARG410
|
3.9
|
41.0
|
1.0
|
N2
|
A:5YX501
|
3.9
|
63.4
|
1.0
|
CD
|
A:ARG410
|
4.0
|
52.6
|
1.0
|
CD2
|
A:HIS407
|
4.1
|
52.2
|
1.0
|
C25
|
A:5YX501
|
4.1
|
55.0
|
1.0
|
C
|
A:ARG410
|
4.2
|
37.8
|
1.0
|
CG
|
A:ARG410
|
4.3
|
52.0
|
1.0
|
C
|
A:HIS407
|
4.4
|
42.8
|
1.0
|
CB
|
A:HIS407
|
4.4
|
37.8
|
1.0
|
CG
|
A:HIS407
|
4.4
|
47.8
|
1.0
|
CA
|
A:HIS407
|
4.5
|
38.5
|
1.0
|
CA
|
A:ARG410
|
4.7
|
38.9
|
1.0
|
CG
|
A:LEU411
|
4.7
|
42.1
|
1.0
|
CD1
|
A:LEU411
|
4.8
|
50.8
|
1.0
|
C9
|
A:5YX501
|
4.8
|
60.4
|
1.0
|
CD1
|
A:ILE414
|
4.8
|
37.6
|
1.0
|
O
|
A:ARG410
|
4.9
|
36.8
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 7rio
Go back to
Fluorine Binding Sites List in 7rio
Fluorine binding site 2 out
of 3 in the Human Pxr Lbd Bound to GSK003
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Pxr Lbd Bound to GSK003 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:52.6
occ:1.00
|
F2
|
A:5YX501
|
0.0
|
52.6
|
1.0
|
C25
|
A:5YX501
|
1.3
|
55.0
|
1.0
|
C24
|
A:5YX501
|
2.3
|
50.3
|
1.0
|
C20
|
A:5YX501
|
2.4
|
53.8
|
1.0
|
N4
|
A:5YX501
|
3.1
|
50.4
|
1.0
|
S3
|
A:5YX501
|
3.1
|
58.3
|
1.0
|
F3
|
A:5YX501
|
3.1
|
53.1
|
1.0
|
O4
|
A:5YX501
|
3.2
|
50.2
|
1.0
|
OG
|
A:SER247
|
3.2
|
37.4
|
1.0
|
C23
|
A:5YX501
|
3.6
|
58.0
|
1.0
|
C21
|
A:5YX501
|
3.6
|
58.4
|
1.0
|
C19
|
A:5YX501
|
4.0
|
50.5
|
1.0
|
CE
|
A:MET425
|
4.0
|
31.7
|
1.0
|
C26
|
A:5YX501
|
4.0
|
54.8
|
1.0
|
C22
|
A:5YX501
|
4.1
|
62.5
|
1.0
|
O
|
A:MET243
|
4.1
|
29.2
|
1.0
|
CB
|
A:SER247
|
4.1
|
32.0
|
1.0
|
CE2
|
A:PHE420
|
4.2
|
37.9
|
1.0
|
C
|
A:MET243
|
4.3
|
37.9
|
1.0
|
CB
|
A:MET243
|
4.3
|
33.7
|
1.0
|
O3
|
A:5YX501
|
4.5
|
57.5
|
1.0
|
N
|
A:ALA244
|
4.6
|
33.3
|
1.0
|
CA
|
A:ALA244
|
4.7
|
38.9
|
1.0
|
CZ
|
A:PHE420
|
4.7
|
42.9
|
1.0
|
CD1
|
A:LEU411
|
4.9
|
50.8
|
1.0
|
CA
|
A:MET243
|
5.0
|
34.4
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 7rio
Go back to
Fluorine Binding Sites List in 7rio
Fluorine binding site 3 out
of 3 in the Human Pxr Lbd Bound to GSK003
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Pxr Lbd Bound to GSK003 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:53.1
occ:1.00
|
F3
|
A:5YX501
|
0.0
|
53.1
|
1.0
|
C26
|
A:5YX501
|
1.4
|
54.8
|
1.0
|
C15
|
A:5YX501
|
2.3
|
44.3
|
1.0
|
C19
|
A:5YX501
|
2.4
|
50.5
|
1.0
|
C6
|
A:5YX501
|
2.7
|
43.2
|
1.0
|
N4
|
A:5YX501
|
2.7
|
50.4
|
1.0
|
C7
|
A:5YX501
|
2.9
|
50.0
|
1.0
|
C8
|
A:5YX501
|
3.1
|
60.9
|
1.0
|
F2
|
A:5YX501
|
3.1
|
52.6
|
1.0
|
OG
|
A:SER247
|
3.3
|
37.4
|
1.0
|
C25
|
A:5YX501
|
3.3
|
55.0
|
1.0
|
N3
|
A:5YX501
|
3.5
|
60.8
|
1.0
|
C9
|
A:5YX501
|
3.6
|
60.4
|
1.0
|
C20
|
A:5YX501
|
3.6
|
53.8
|
1.0
|
C16
|
A:5YX501
|
3.6
|
54.8
|
1.0
|
C18
|
A:5YX501
|
3.6
|
44.8
|
1.0
|
N1
|
A:5YX501
|
3.7
|
47.3
|
1.0
|
CE
|
A:MET243
|
3.7
|
52.0
|
1.0
|
S3
|
A:5YX501
|
3.8
|
58.3
|
1.0
|
C24
|
A:5YX501
|
4.1
|
50.3
|
1.0
|
C17
|
A:5YX501
|
4.1
|
45.2
|
1.0
|
C11
|
A:5YX501
|
4.3
|
61.3
|
1.0
|
S1
|
A:5YX501
|
4.3
|
51.3
|
1.0
|
C10
|
A:5YX501
|
4.4
|
61.2
|
1.0
|
C5
|
A:5YX501
|
4.5
|
51.5
|
1.0
|
C21
|
A:5YX501
|
4.5
|
58.4
|
1.0
|
CB
|
A:SER247
|
4.7
|
32.0
|
1.0
|
O
|
A:MET243
|
4.7
|
29.2
|
1.0
|
CB
|
A:MET243
|
4.7
|
33.7
|
1.0
|
O3
|
A:5YX501
|
4.7
|
57.5
|
1.0
|
N2
|
A:5YX501
|
4.7
|
63.4
|
1.0
|
O4
|
A:5YX501
|
4.8
|
50.2
|
1.0
|
C23
|
A:5YX501
|
4.9
|
58.0
|
1.0
|
|
Reference:
J.M.Ramajulu,
S.P.Williams,
A.S.Lakdawala,
M.P.Demartino,
Y.Lan,
R.W.Marquis.
Overcoming the Pxr Liability: Rationale Design to Eliminate Pxr Mediated Cyp Induction Acs Med.Chem.Lett. V. 12 2021.
ISSN: ISSN 1948-5875
DOI: 10.1021/ACSMEDCHEMLETT.1C00187
Page generated: Fri Aug 2 12:06:55 2024
|